Patients with lung cancer treated with immune checkpoint inhibitors are at significantly higher risk for certain major cardiovascular adverse events. Patients with lung cancer treated with immune ...

Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the ...

Pioneering liquid biopsy platform for early lung cancer detection strengthens IP and accelerates commercial strategy in China and Japan diagnostic markets. Vancouver, British Columbia–(Newsfile Corp.

An expert discusses how the IMpower133 trial established atezolizumab plus chemotherapy as standard care for extensive-stage small cell lung cancer, improving overall survival from 10.3 to 12.3 months ...

These findings indicate that the addition of atezolizumab or durvalumab to platinum-doublet chemotherapy improves the ORR and ...

Helena Yu, MD, medical oncologist at Memorial Sloan Kettering Cancer Center, discusses the treatment landscape of EGFR exon 20 insertion (ex20ins)-mutated non–small cell lung cancer (NSCLC) and how ...

Robotic bronchoscopy with cold beam CT showed superior diagnostic yield over conventional bronchoscopy in early lung cancer, ...

ES-SCLC accounts for the majority of small-cell lung cancer diagnoses and is characterized by rapid progression and poor ...

Physicians and scientists from the UCLA Health Jonsson Comprehensive Cancer Center will share the latest research and ...

Prostate cancer is the second-leading cause of death in American men. However, prostate cancer is curable, thanks to options ...

Ibtrozi may become the new standard for ROS1-mutated lung cancer, with phase 2 data showing safer, longer-lasting benefits ...

A new targeted therapy has shown promise for a difficult-to-treat subset of lung cancer. In a multinational phase 2 trial, the oral drug sunvozertinib produced durable tumor responses in patients with ...